The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has advised patients with pre-existing myasthenia gravis to be cautious when taking statins, as there have been reports of new-onset or worsening of the condition. Myasthenia gravis is a neuromuscular disorder characterized by muscle weakness. Statins are medications used to lower cholesterol levels and reduce the risk of cardiovascular disease.